FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Francisco Fábregues

Research Profile

Living Beings

Fertilizations in Vitro

Procedures

Disorders

Physiology

Pregnancy

Chemicals & Drugs

Concepts & Ideas

Anatomy

Co-author Network

Publications

TOP 3
Gemma Casals; Francisco Fábregues; Marco Pavesi; Vicente Arroyo; Juan Balasch
Conservative medical treatment of ovarian hyperstimulation syndrome: a single center series and cost analysis study.
Francisco Fábregues; Francisco Carmona; Gemma Casals; Montserrat Creus; Juan Balasch
Outcome from consecutive ICSI cycles in patients treated with recombinant human LH and those supplemented with urinary hCG-based LH activity during controlled ovarian stimulation in the long GnRH-agonist protocol.
Mireia González-Comadran; Ivan Solà; Ramon Carreras; Montserrat Durán; Francisco Fábregues; Miguel A Checa
Effects of transdermal testosterone in poor responders undergoing IVF: systematic review and meta-analysis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Francisco Fábregues (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Gemma Casals; Francisco Fábregues; Marco Pavesi; Vicente Arroyo; Juan Balasch
Conservative medical treatment of ovarian hyperstimulation syndrome: a single center series and cost analysis study.
Acta obstetricia et gynecologica Scandinavica 2013;92(6):686-91.
2013: Francisco Fábregues; Francisco Carmona; Gemma Casals; Montserrat Creus; Juan Balasch
Outcome from consecutive ICSI cycles in patients treated with recombinant human LH and those supplemented with urinary hCG-based LH activity during controlled ovarian stimulation in the long GnRH-agonist protocol.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2013;29(5):430-5.
2012: Mireia González-Comadran; Ivan Solà; Ramon Carreras; Montserrat Durán; Francisco Fábregues; Miguel A Checa
Effects of transdermal testosterone in poor responders undergoing IVF: systematic review and meta-analysis.
Reproductive biomedicine online 2012;25(5):450-9.
2012: Francisco Fábregues; Ainara Iraola; Francisco Carmona; Roser Casamitjana; Juan Balasch
Human chorionic gonadotrophin stimulation test as a predictor of ovarian response and pregnancy in IVF cycles stimulated with GnRH agonist gonadotrophin treatment: a pilot study.
Human reproduction (Oxford, England) 2012;27(4):1122-9.
2012: Gemma Casals; Roser Casamitjana; Montserrat Creus; Francisco Fábregues; Jaume Ordi; Francisco Carmona; Juan Balasch
Expression pattern of osteopontin and αvβ3 integrin during the implantation window in infertile patients with early stages of endometriosis.
Human reproduction (Oxford, England) 2012;27(3):805-13.
2011: Francisco Fábregues; Ainara Iraola; Francisco Carmona; Gemma Casals; Montserrat Creus; Juan Balasch
Evaluation of two doses of recombinant human luteinizing hormone supplementation in down-regulated women of advanced reproductive age undergoing follicular stimulation for IVF: a randomized clinical study.
European journal of obstetrics, gynecology, and reproductive biology 2011;158(1):56-61.
2011: Francisco Fábregues; Camil Castelo-Branco; Francisco Carmona; Marta Guimerá; Roser Casamitjana; Juan Balasch
The effect of different hormone therapies on anti-müllerian hormone serum levels in anovulatory women of reproductive age.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2011;27(4):216-24.
2010: Joana Peñarrubia; Sara Peralta; Francisco Fábregues; Francisco Carmona; Roser Casamitjana; Juan Balasch
Day-5 inhibin B serum concentrations and antral follicle count as predictors of ovarian response and live birth in assisted reproduction cycles stimulated with gonadotropin after pituitary suppression.
Fertility and sterility 2010;94(7):2590-5.
2010: Gemma Casals; Jaume Ordi; Montserrat Creus; Francisco Fábregues; Francisco Carmona; Roser Casamitjana; Juan Balasch
Osteopontin and alphavbeta3 integrin as markers of endometrial receptivity: the effect of different hormone therapies.
Reproductive biomedicine online 2010;21(3):349-59.
2009: Juan Balasch; Francisco Fábregues; Francisco Carmona; Roser Casamitjana; Manuel Tena-Sempere
Ovarian luteinizing hormone priming preceding follicle-stimulating hormone stimulation: clinical and endocrine effects in women with long-term hypogonadotropic hypogonadism.
The Journal of clinical endocrinology and metabolism 2009;94(7):2367-73.
2009: Francisco Fábregues; Joana Peñarrubia; Montserrat Creus; Dolors Manau; Gemma Casals; Francisco Carmona; Juan Balasch
Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial.
Human reproduction (Oxford, England) 2009;24(2):349-59.
2008: Montserrat Creus; Francisco Fábregues; Francisco Carmona; Marta del Pino; Dolors Manau; Juan Balasch
Combined laparoscopic surgery and pentoxifylline therapy for treatment of endometriosis-associated infertility: a preliminary trial.
Human reproduction (Oxford, England) 2008;23(8):1910-6.
2008: Gemma Casals; Jaume Ordi; Montserrat Creus; Francisco Fábregues; Roser Casamitjana; Llorenç Quinto; Elias Campo; Juan Balasch
Osteopontin and alphavbeta3 integrin expression in the endometrium of infertile and fertile women.
Reproductive biomedicine online 2008;16(6):808-16.
2007: Dolors Manau; Francisco Fábregues; Joana Peñarrubia; Montserrat Creus; Francisco Carmona; Gemma Casals; Wladimiro Jiménez; Juan Balasch
Vascular endothelial growth factor levels in serum and plasma from patients undergoing controlled ovarian hyperstimulation for IVF.
Human reproduction (Oxford, England) 2007;22(3):669-75.
2006: Juan Balasch; Francisco Fábregues; Joana Peñarrubia; Francisco Carmona; Roser Casamitjana; Montserrat Creus; Dolors Manau; Gemma Casals; Juan A Vanrell
Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH.
Human reproduction (Oxford, England) 2006;21(7):1884-93.
2006: Juan Balasch; Francisco Fábregues
LH in the follicular phase: neither too high nor too low.
Reproductive biomedicine online 2006;12(4):406-15.
2006: Francisco Fábregues; Montserrat Creus; Joana Peñarrubia; Dolors Manau; Juan A Vanrell; Juan Balasch
Effects of recombinant human luteinizing hormone supplementation on ovarian stimulation and the implantation rate in down-regulated women of advanced reproductive age.
Fertility and sterility 2006;85(4):925-31.
2005: Joana Peñarrubia; Francisco Fábregues; Dolors Manau; Montserrat Creus; Gemma Casals; Roser Casamitjana; Francisco Carmona; Juan A Vanrell; Juan Balasch
Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
Human reproduction (Oxford, England) 2005;20(4):915-22.
2005: Francisco Fábregues; Joana Peñarrubia; Montserrat Creus; Roser Casamitjana; Juan A Vanrell; Juan Balasch
Effect of halving the daily dose of triptorelin at the start of ovarian stimulation on hormone serum levels and the outcome of in vitro fertilization.
Fertility and sterility 2005;83(3):785-8.
2005: Joana Peñarrubia; Francisco Fábregues; Dolors Manau; Montserrat Creus; Francisco Carmona; Roser Casamitjana; Juan A Vanrell; Juan Balasch
Previous cycle cancellation due to poor follicular development as a predictor of ovarian response in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment.
Human reproduction (Oxford, England) 2005;20(3):622-8.
2004: Francisco Fábregues; Joana Peñarrubia; Ester Vidal; Gemma Casals; Juan A Vanrell; Juan Balasch
Oocyte quality in patients with severe ovarian hyperstimulation syndrome: a self-controlled clinical study.
Fertility and sterility 2004;82(4):827-33.
2004: Juan Balasch; Francisco Fábregues; Joana Peñarrubia; Montserrat Creus; Dolors Manau; Ester Vidal; Roser Casamitjana; Juan A Vanrell
Outcome from consecutive assisted reproduction cycles in patients treated with recombinant follitropin alfa filled-by-bioassay and those treated with recombinant follitropin alfa filled-by-mass.
Reproductive biomedicine online 2004;8(4):408-13.
2004: Francisco Fábregues; Dolors Tàssies; Joan Carles Reverter; Francisco Carmona; Antonio Ordinas; Juan Balasch
Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
Fertility and sterility 2004;81(4):989-95.
2004: Joana Peñarrubia; Francisco Fábregues; Dolors Manau; Montserrat Creus; Roser Casamitjana; Francisco Carmona; Juan A Vanrell; Juan Balasch
Initial analysis of variability among basal hormone biomarkers of ovarian reserve.
Reproductive biomedicine online 2004;8(2):191-5.
2003: Francisco Carmona; Juan Balasch; Montserrat Creus; Francisco Fábregues; Roser Casamitjana; Salvadora Cívico; Ester Vidal; Josep M Calafell; Vicenta Moreno; Juan A Vanrell
Early hormonal markers of pregnancy outcome after in vitro fertilization and embryo transfer.
Journal of assisted reproduction and genetics 2003;20(12):521-6.
2003: Joana Peñarrubia; Francisco Fábregues; Montserrat Creus; Dolors Manau; Roser Casamitjana; Marta Guimerá; Francisco Carmona; Juan A Vanrell; Juan Balasch
LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH.
Human reproduction (Oxford, England) 2003;18(12):2689-97.
2003: Montserrat Creus; Josep M Calafell; Salvadora Cívico; Francisco Fábregues; Francisco Carmona; Juan A Vanrell; Juan Balasch
Materno-fetal immunogenetic disparity: the biological basis for in vitro fertilization treatment in patients with unexplained recurrent abortion?
American journal of reproductive immunology (New York, N.Y. : 1989) 2003;50(5):420-6.
2003: Juan Balasch; Joana Peñarrubia; Francisco Fábregues; Ester Vidal; Roser Casamitjana; Dolors Manau; Francisco Carmona; Montserrat Creus; Juan A Vanrell
Ovarian responses to recombinant FSH or HMG in normogonadotrophic women following pituitary desensitization by a depot GnRH agonist for assisted reproduction.
Reproductive biomedicine online 2003;7(1):35-42.
2003: Juan Balasch; Francisco Fábregues
Pregnancy after administration of high dose recombinant human LH alone to support final stages of follicular maturation in a woman with long-standing hypogonadotrophic hypogonadism.
Reproductive biomedicine online 2003;6(4):427-31.
2003: Juan Balasch; Francisco Fábregues; Roser Casamitjana; Joana Peñarrubia; Juan A Vanrell
A pharmacokinetic and endocrine comparison of recombinant follicle-stimulating hormone and human menopausal gonadotrophin in polycystic ovary syndrome.
Reproductive biomedicine online 2003;6(3):296-301.
2003: Montserrat Creus; Jaume Ordi; Francisco Fábregues; Roser Casamitjana; Francisco Carmona; Antonio Cardesa; Juan A Vanrell; Juan Balasch
The effect of different hormone therapies on integrin expression and pinopode formation in the human endometrium: a controlled study.
Human reproduction (Oxford, England) 2003;18(4):683-93.
2002: Dolors Manau; Francisco Fábregues; Vicente Arroyo; Wladimiro Jiménez; Juan A Vanrell; Juan Balasch
Hemodynamic changes induced by urinary human chorionic gonadotropin and recombinant luteinizing hormone used for inducing final follicular maturation and luteinization.
Fertility and sterility 2002;78(6):1261-7.
2002: Montserrat Creus; Jaume Ordi; Francisco Fábregues; Roser Casamitjana; Berta Ferrer; Elisenda Coll; Juan A Vanrell; Juan Balasch
alphavbeta3 integrin expression and pinopod formation in normal and out-of-phase endometria of fertile and infertile women.
Human reproduction (Oxford, England) 2002;17(9):2279-86.
2002: Jaume Ordi; Montserrat Creus; Berta Ferrer; Francisco Fábregues; Francisco Carmona; Roser Casamitjana; Juan A Vanrell; Juan Balasch
Midluteal endometrial biopsy and alphavbeta3 integrin expression in the evaluation of the endometrium in infertility: implications for fecundity.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2002;21(3):231-8.
2002: Dolors Manau; Vicente Arroyo; Wladimiro Jiménez; Francisco Fábregues; Juan A Vanrell; Juan Balasch
Chronology of hemodynamic changes in asymptomatic in vitro fertilization patients and relationship with ovarian steroids and cytokines.
Fertility and sterility 2002;77(6):1178-83.
2002: Juan Balasch; Francisco Fábregues
Is luteinizing hormone needed for optimal ovulation induction?
Current opinion in obstetrics & gynecology 2002;14(3):265-74.
2001: Francisco Carmona; J Font; M Azulay; Montserrat Creus; Francisco Fábregues; Ricard Cervera; Bienvenido Puerto; Juan Balasch
Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis.
American journal of reproductive immunology (New York, N.Y. : 1989) 2001;46(4):274-9.
2001: Juan Balasch; Ester Vidal; Joana Peñarrubia; Roser Casamitjana; Francisco Carmona; Montserrat Creus; Francisco Fábregues; Juan A Vanrell
Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH.
Human reproduction (Oxford, England) 2001;16(8):1636-43.
2001: Montserrat Creus; Jaume Ordi; Francisco Fábregues; Roser Casamitjana; Juan A Vanrell; Juan Balasch
Mid-luteal serum inhibin-A concentration as a marker of endometrial differentiation.
Human reproduction (Oxford, England) 2001;16(7):1347-52.
2001: Juan Balasch; Montserrat Creus; Francisco Fábregues; Salvadora Civico; Francisco Carmona; Bienvenido Puerto; Roser Casamitjana; Juan A Vanrell
The effect of exogenous luteinizing hormone (LH) on oocyte viability: evidence from a comparative study using recombinant human follicle-stimulating hormone (FSH) alone or in combination with recombinant LH for ovarian stimulation in pituitary-suppressed women undergoing assisted reproduction.
Journal of assisted reproduction and genetics 2001;18(5):250-6.
2001: Juan Balasch; Francisco Fábregues; Montserrat Creus; Bienvenido Puerto; Joana Peñarrubia; Juan A Vanrell
Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modified step-down regimens.
Human reproduction (Oxford, England) 2001;16(4):652-6.
2000: Juan Balasch; Francisco Fábregues; Montserrat Creus; Roser Casamitjana; Bienvenido Puerto; Juan A Vanrell
Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: a prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol.
Journal of assisted reproduction and genetics 2000;17(10):561-5.
2000: Montserrat Creus; Joana Peñarrubia; Francisco Fábregues; Ester Vidal; Francisco Carmona; Roser Casamitjana; Juan A Vanrell; Juan Balasch
Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome.
Human reproduction (Oxford, England) 2000;15(11):2341-6.
2000: José L Ballescá; Juan Balasch; Josep M Calafell; R Alvarez; Francisco Fábregues; M J de Osaba; Carlos Ascaso; Juan A Vanrell
Serum inhibin B determination is predictive of successful testicular sperm extraction in men with non-obstructive azoospermia.
Human reproduction (Oxford, England) 2000;15(8):1734-8.
2000: Francisco Fábregues; Juan Balasch; Dolors Manau; Montserrat Creus; Wladimiro Jiménez; Francisco Carmona; Roser Casamitjana; Juan A Vanrell
Circulating levels of nitric oxide in successful and unsuccessful implantation after in vitro fertilization and embryo transfer. Relationship to estradiol and progesterone.
Acta obstetricia et gynecologica Scandinavica 2000;79(7):564-9.
2000: Joana Peñarrubia; Juan Balasch; Francisco Fábregues; Francisco Carmona; Roser Casamitjana; Vicenta Moreno; Josep M Calafell; Juan A Vanrell
Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment.
Human reproduction (Oxford, England) 2000;15(7):1499-504.
2000: Dolors Manau; Juan Balasch; Wladimiro Jiménez; Francisco Fábregues; Salvadora Civico; Roser Casamitjana; Montserrat Creus; Juan A Vanrell
Follicular fluid concentrations of adrenomedullin, vascular endothelial growth factor and nitric oxide in IVF cycles: relationship to ovarian response.
Human reproduction (Oxford, England) 2000;15(6):1295-9.
2000: Juan Balasch; Francisco Fábregues; Montserrat Creus; Joana Peñarrubia; Ester Vidal; Francisco Carmona; Bienvenido Puerto; Juan A Vanrell
Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women undergoing ovarian stimulation after pituitary suppression for in vitro fertilization: implications for implantation potential.
Journal of assisted reproduction and genetics 2000;17(1):20-7.
2000: Francisco Fábregues; Juan Balasch; Montserrat Creus; Francisco Carmona; Bienvenido Puerto; L Quintó; R Casamitjana; Juan A Vanrell
Ovarian reserve test with human menopausal gonadotropin as a predictor of in vitro fertilization outcome.
Journal of assisted reproduction and genetics 2000;17(1):13-9.
1999: Juan Balasch; Joan Carles Reverter; Montserrat Creus; Dolors Tàssies; Francisco Fábregues; Francisco Carmona; Josep Font; Juan A Vanrell
Human reproductive failure is not a clinical feature associated with beta(2) glycoprotein-I antibodies in anticardiolipin and lupus anticoagulant seronegative patients (the antiphospholipid/cofactor syndrome)
Human reproduction (Oxford, England) 1999;14(8):1956-9.
1999: Dolors Manau; Juan Balasch; Wladimiro Jiménez; Francisco Fábregues; Roser Casamitjana; Montserrat Creus; Vicente Arroyo; Juan A Vanrell
Adrenomedullin and nitric oxide in menstrual and in vitro fertilization cycles. Relationship to estradiol.
Acta obstetricia et gynecologica Scandinavica 1999;78(7):626-31.
1999: Joana Peñarrubia; Juan Balasch; Francisco Fábregues; Montserrat Creus; Salvadora Cívico; Juan A Vanrell
Recurrent empty follicle syndrome successfully treated with recombinant human chorionic gonadotrophin.
Human reproduction (Oxford, England) 1999;14(7):1703-6.
1999: Francisco Fábregues; Juan Balasch; P Ginès; Dolors Manau; Wladimiro Jiménez; Vicente Arroyo; Montserrat Creus; Juan A Vanrell
Ascites and liver test abnormalities during severe ovarian hyperstimulation syndrome.
The American journal of gastroenterology 1999;94(4):994-9.
1998: Montserrat Creus; Juan Balasch; Jaume Ordi; Francisco Fábregues; Roser Casamitjana; Llorenç Quinto; C Coutifaris; Juan A Vanrell
Integrin expression in normal and out-of-phase endometria.
Human reproduction (Oxford, England) 1998;13(12):3460-8.
1998: Joana Peñarrubia; Juan Balasch; Francisco Fábregues; Montserrat Creus; Roser Casamitjana; José L Ballescá; Bienvenido Puerto; Juan A Vanrell
Human chorionic gonadotrophin luteal support overcomes luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cycles.
Human reproduction (Oxford, England) 1998;13(12):3315-8.
1998: Juan Balasch; Francisco Fábregues; Joana Peñarrubia; Montserrat Creus; R Vidal; Roser Casamitjana; Dolors Manau; Juan A Vanrell
Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women and WHO group II anovulatory infertile patients.
Journal of assisted reproduction and genetics 1998;15(9):552-9.
1998: Juan Balasch; Francisco Fábregues; Vicente Arroyo
Peripheral arterial vasodilation hypothesis: a new insight into the pathogenesis of ovarian hyperstimulation syndrome.
Human reproduction (Oxford, England) 1998;13(1O):2718-30.
1998: Francisco Fábregues; Juan Balasch; Dolors Manau; Wladimiro Jiménez; Vicente Arroyo; Montserrat Creus; F Rivera; Juan A Vanrell
Haematocrit, leukocyte and platelet counts and the severity of the ovarian hyperstimulation syndrome.
Human reproduction (Oxford, England) 1998;13(9):2406-10.
1998: Francisco Fábregues; Juan Balasch; Montserrat Creus; Salvadora Cívico; Francisco Carmona; Bienvenido Puerto; Juan A Vanrell
Long-term down-regulation does not improve pregnancy rates in an in vitro fertilization program.
Fertility and sterility 1998;70(1):46-51.
1998: Juan Balasch; Montserrat Creus; Francisco Fábregues; Salvadora Cívico; Joan Carles Reverter; Francisco Carmona; Dolors Tàssies; Juan A Vanrell
Antiphospholipid antibodies and the outcome of pregnancy after the first in-vitro fertilization and embryo transfer cycle.
Human reproduction (Oxford, England) 1998;13(5):1180-3.
1998: Dolors Manau; Juan Balasch; Vicente Arroyo; Wladimiro Jiménez; Francisco Fábregues; Roser Casamitjana; Montserrat Creus; Juan A Vanrell
Circulatory dysfunction in asymptomatic in vitro fertilization patients. Relationship with hyperestrogenemia and activity of endogenous vasodilators.
The Journal of clinical endocrinology and metabolism 1998;83(5):1489-93.
1998: Montserrat Creus; Juan Balasch; Francisco Fábregues; J Martorell; Montserrat Boada; Joana Peñarrubia; Pedro N Barri; Juan A Vanrell
Parental human leukocyte antigens and implantation failure after in-vitro fertilization.
Human reproduction (Oxford, England) 1998;13(1):39-43.
1997: Sergio Martínez-Román; Juan Balasch; Montserrat Creus; Francisco Fábregues; Francisco Carmona; R Vilella; Juan A Vanrell
Transferrin receptor (CD71) expression in peritoneal macrophages from fertile and infertile women with and without endometriosis.
American journal of reproductive immunology (New York, N.Y. : 1989) 1997;38(6):413-7.
1997: Juan Balasch; Montserrat Creus; Francisco Fábregues; Francisco Carmona; Sergio Martínez-Román; Dolors Manau; Juan A Vanrell
Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: a pilot randomized clinical trial.
Human reproduction (Oxford, England) 1997;12(9):2046-50.
1997: Sergio Martínez-Román; Juan Balasch; Montserrat Creus; Francisco Fábregues; Francisco Carmona; R Vilella; Juan A Vanrell
Immunological factors in endometriosis-associated reproductive failure: studies in fertile and infertile women with and without endometriosis.
Human reproduction (Oxford, England) 1997;12(8):1794-9.
1997: J Balasch; Joan Carles Reverter; Francisco Fábregues; Dolors Tàssies; M Rafel; Montserrat Creus; J A Vanrell
First-trimester repeated abortion is not associated with activated protein C resistance.
Human reproduction (Oxford, England) 1997;12(5):1094-7.
1997: Juan Balasch; Francisco Fábregues; Montserrat Creus; Juan A Vanrell
Sequential danazol/leuprolide acetate therapy for ovarian suppression in an in vitro fertilization patient unresponsive to leuprolide acetate.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 1997;11(1):21-4.
1996: Juan Balasch; Francisco Fábregues; J Ordi; Montserrat Creus; Joana Peñarrubia; Roser Casamitjana; Dolors Manau; Juan A Vanrell
Further data favoring the hypothesis of the uterine first-pass effect of vaginally administered micronized progesterone.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 1996;10(6):421-6.
1996: Juan Balasch; Montserrat Creus; Francisco Fábregues; Roser Casamitjana; J Ordi; Juan A Vanrell
Midluteal immunoreactive alpha-inhibin serum concentrations as markers of luteal phase deficiency.
Human reproduction (Oxford, England) 1996;11(12):2591-4.
1996: Juan Balasch; Francisco Fábregues; Montserrat Creus; V Moreno; Bienvenido Puerto; Joana Peñarrubia; Francisco Carmona; Juan A Vanrell
Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.
Human reproduction (Oxford, England) 1996;11(11):2400-4.
1996: Juan Balasch; Montserrat Creus; Francisco Fábregues; Francisco Carmona; Roser Casamitjana; Carlos Ascaso; Juan A Vanrell
Inhibin, follicle-stimulating hormone, and age as predictors of ovarian response in in vitro fertilization cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment.
American journal of obstetrics and gynecology 1996;175(5):1226-30.
1996: Juan Balasch; Montserrat Creus; Francisco Fábregues; Joan Carles Reverter; Francisco Carmona; Dolors Tàssies; Josep Font; Juan A Vanrell
Antiphospholipid antibodies and human reproductive failure.
Human reproduction (Oxford, England) 1996;11(10):2310-5.
1996: Juan Balasch; Joan Carles Reverter; Francisco Fábregues; Dolors Tàssies; Antonio Ordinas; Juan A Vanrell
Increased induced monocyte tissue factor expression by plasma from patients with severe ovarian hyperstimulation syndrome.
Fertility and sterility 1996;66(4):608-13.
1996: Juan Balasch; Francisco Fábregues; Vicente Arroyo; Wladimiro Jiménez; Montserrat Creus; Juan A Vanrell
Treatment of severe ovarian hyperstimulation syndrome by a conservative medical approach.
Acta obstetricia et gynecologica Scandinavica 1996;75(7):662-7.
1996: Juan Balasch; Montserrat Creus; Francisco Fábregues; J Font; Jaume Martorell; Juan A Vanrell
Intravenous immunoglobulin preceding in vitro fertilization-embryo transfer for patients with repeated failure of embryo transfer.
Fertility and sterility 1996;65(3):655-8.
1996: Juan Balasch; Montserrat Creus; Francisco Fábregues; Francisco Carmona; J Ordi; S Martinez-Román; Juan A Vanrell
Visible and non-visible endometriosis at laparoscopy in fertile and infertile women and in patients with chronic pelvic pain: a prospective study.
Human reproduction (Oxford, England) 1996;11(2):387-91.
1995: Juan Balasch; Vicente Arroyo; Francisco Fábregues; Wladimiro Jiménez; Joan Saló; Juan A Vanrell
Immunoreactive endothelin plasma levels in severe ovarian hyperstimulation syndrome.
Fertility and sterility 1995;64(1):65-8.
1995: Juan Balasch; Francisco Fábregues; R Tur; Montserrat Creus; Roser Casamitjana; Joana Peñarrubia; Pedro N Barri; Juan A Vanrell
Further characterization of the luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cycles.
Human reproduction (Oxford, England) 1995;10(6):1377-81.
1995: Juan Balasch; Montserrat Creus; Francisco Fábregues; Francisco Carmona; Roser Casamitjana; Joana Peñarrubia; F Rivera; Juan A Vanrell
Hormonal profiles in successful and unsuccessful implantation in IVF-ET after combined GnRH agonist/gonadotropin treatment for superovulation and hCG luteal support.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 1995;9(1):51-8.
1994: Juan Balasch; José L Ballescá; C Pimentel; Montserrat Creus; Francisco Fábregues; Juan A Vanrell
Late low-dose pure follicle stimulating hormone for ovarian stimulation in intra-uterine insemination cycles.
Human reproduction (Oxford, England) 1994;9(10):1863-6.
1994: Juan Balasch; Vicente Arroyo; Francisco Fábregues; Joan Saló; Wladimiro Jiménez; J C Paré; Juan A Vanrell
Neurohormonal and hemodynamic changes in severe cases of the ovarian hyperstimulation syndrome.
Annals of internal medicine 1994;121(1):27-33.
1994: Juan Balasch; R Tur; Montserrat Creus; R Buxaderas; Francisco Fábregues; José L Ballescá; Pedro N Barri; Juan A Vanrell
Triggering of ovulation by a gonadotropin releasing hormone agonist in gonadotropin-stimulated cycles for prevention of ovarian hyperstimulation syndrome and multiple pregnancy.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 1994;8(1):7-12.
1994: Aureli Torné; J Pahisa; Camil Castelo-Branco; Francisco Fábregues; C Mallofré; Xavier Iglesias
Solitary vaginal metastasis as a presenting form of unsuspected renal adenocarcinoma.
Gynecologic oncology 1994;52(2):260-3.
1993: Juan Balasch; Francisco Carmona; Alfonso López-Soto; Josep Font; Montserrat Creus; Francisco Fábregues; M Ingelmo; Juan A Vanrell
Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome.
Human reproduction (Oxford, England) 1993;8(12):2234-9.
1993: Juan Balasch; J Pahisa; M Márquez; J Ordi; Francisco Fábregues; Bienvenido Puerto; Juan A Vanrell
Metastatic ovarian strumosis in an in-vitro fertilization patient.
Human reproduction (Oxford, England) 1993;8(12):2075-7.
1992: Juan Balasch; J L Ballesca; Francisco Fábregues; Bienvenido Puerto; R Casamitjana; Juan A Vanrell
Transvaginal intratubal insemination, ectopic pregnancy and treatment by single-dose parenteral methotrexate.
Human reproduction (Oxford, England) 1992;7(10):1457-60.
1992: Juan Balasch; Francisco Fábregues; Montserrat Creus; Juan A Vanrell
The usefulness of endometrial biopsy for luteal phase evaluation in infertility.
Human reproduction (Oxford, England) 1992;7(7):973-7.
1992: Juan Balasch; Tomás Pumarola; Francisco Fábregues; I Jové; Juan A Vanrell
Results of routine syphilitic and human immunodeficiency virus (HIV) serology in infertility.
Human reproduction (Oxford, England) 1992;7(7):970-2.
1992: Francisco Carmona; Francisco Fábregues; R Alvarez; J Vila; Vicenç Cararach
A rare case of chorioamnionitis by Morganella morganii complicated by septicemia and adult respiratory distress syndrome.
European journal of obstetrics, gynecology, and reproductive biology 1992;45(1):67-70.
1992: Juan Balasch; Francisco Fábregues; I C Jové; Francisco Carmona; Juan A Vanrell
Infertility factors and pregnancy outcome in women above age 35.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 1992;6(1):31-5.